替罗非班致急性重度血小板减少症2例
张强,吴彩凤,徐日新
摘要(Abstract)：
<正>1临床资料病例1患者男,60岁。因"突发胸痛1 h"于2014年8月6日就诊于苏北人民医院。入院1 h前患者突发胸痛,伴胸骨段灼烧感及左肩部疼痛,伴大汗,持续不缓解。既往有高血压病,冠心病,经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)史。入院查体:血压140/100 mmHg(1 mm Hg=0.133 k Pa),神志清,双肺呼吸音清,未闻及啰音;心界无扩大,心率58次/分,律齐,各瓣膜听诊区未及杂音,周围血管征阴性;腹部无阳性体征,双下肢无水肿。入院心电图示:窦性心动过缓,Ⅲ、a VF导联异常Q波。心肌损伤标志物正常。初步诊断:非ST段抬高型心肌梗死,Killip心功能分级Ⅰ级,冠心
关键词(KeyWords)： 替罗非班;血小板减少;经皮冠状动脉介入治疗
基金项目(Foundation): 扬州市科技局发展面上项目(YZ2016076)
作者(Author): 张强,吴彩凤,徐日新
参考文献(References)：
- [1] Wiliamson DR,Albert M, Heels-Ansdell D, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis:frequency,risk factors, and outcomes. Chest,2013,144(4):1207-1215.
- [2] Vicaria A, Banfib G, Boninib PA. EDTA-dependent pseudothrombocytopaenia:a 12-month epidemiological study. Scand J Clin Lab Invest,1988,48(6):537-542.
- [3] Meghrajani V, Sabharwal N, Namana V, et al. A case of hyperacute severe thrombocytopenia occurring less than 24 hours after intravenous tirofiban infusion. Case RepHematol,2018,2018:4357981.
- [4] Huxtable LM, Tafreshi MJ, Rakkar AN. Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists. Am J Cardiol, 2005, 97(3):426-429.
- [5]李月平,周玉杰,刘宇扬,等.经皮冠状动脉介入治疗术后替罗非班诱发极重度血小板减少症二例.中国介入心脏病学杂志,2006,14(5):315-316.
- [6] Demirkan B, Guray Y, Guray U, et al. Differential diagnosis and management of acute profound thrombocytopenia by tirofiban:a case report. J Thromb Thrombolysis, 2006,22(1):77-78.
- [7] Teke H, Teke D. Profound thrombocytopenia related with tirofiban:will it be enough to only stop medicine? Platelets,2013,24(4):335-337.
- [8] Dursunoglu D, Taskoylu O, Gür S, et al. Tirofiban-induced acute profound thrombocytopenia after primary angioplasty. Asian Cardiovasc Thorac Ann,2013,21(1):74-76.
- [9]华倚虹.替罗非班相关的血小板减少症诊治流程及病例分析.中国介入心脏病学杂志,2015,23(1):48-50.
- [10] Li Y, Xu Q, Guo X. Thromboembolic events secondary to tirofiban-induced thrombocytopenia being treated with thrombopoietin:A case report. Exp Ther Med, 2016, 12(2):1177-1180.